Genetics of antipsychotic-induced side effects and agranulocytosis. - Wikidata - wikimedia - TriplyDB

Genetics of antipsychotic-induced side effects and agranulocytosis.

Genetics of antipsychotic-induced side effects and agranulocytosis.

http://www.wikidata.org/entity/Q37845227

about

Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics Pharmacogenetics of antipsychotic-induced movement disorders as a resource for better understanding Parkinson's disease modifier genes Pharmacogenetics of antipsychotics.Pharmacogenomics and personalized medicine in neuropsychiatry.Personalized medicine in psychiatry: problems and promises.Establishing the characteristics of an effective pharmacogenetic test for clozapine-induced agranulocytosis.TOX and ADIPOQ Gene Polymorphisms Are Associated with Antipsychotic-Induced Weight Gain in Han Chinese.Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.Opening Pandora's box in the UK: a hypothetical pharmacogenetic test for clozapine.Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis.Genome-wide association study of lymphoblast cell viability after clozapine exposure.Exome sequence analysis of Finnish patients with clozapine-induced agranulocytosis.Correlation Between Serum Concentrations of N-Desmethylclozapine and Granulocyte Levels in Patients with Schizophrenia: A Retrospective Observational Study.Genetic risk factors for clozapine-induced neutropenia and agranulocytosis in a Dutch psychiatric population.How close are we to a pharmacogenomic test for clozapine-induced agranulocytosis?

P2860

Q28079065-B1677324-6CF9-4E7C-B7CA-4AEE189B7FEB Q28088705-AF946B55-61C7-4C32-8A2B-04BB0F77CDD6 Q33836837-33F94B60-1743-4C4D-B8C2-C412F75012AF Q34280025-AF66630A-334F-47E7-B7CF-32E217DDE8EB Q34726454-911363BA-214C-4E44-A8BA-89392F4FFDF7 Q36605131-34B54CDB-A800-4DC1-8634-F93B8FF0EF89 Q37714911-DFFA9B04-E979-4AF4-BD9C-E2F4C4924937 Q37926893-E1032FF1-8CB0-4EDD-A231-9CA34458771A Q38162870-288FD4EB-6FCE-42DE-B41C-516801996F7D Q38271339-19A2DD96-3166-485A-8AA7-4C28195185EC Q38967700-E28E459D-F328-468A-A68E-F58F81831CE4 Q44586735-DFB70802-B5BB-4B07-B4DF-5B1E1DC950DC Q47613439-D780A014-D7E2-4D23-9B6E-A524A07FFB77 Q48026160-B7CB8B87-828B-4F47-A40D-B47F419EFE3D Q59159520-3046463E-7BD5-4948-BA2D-F4644A8EC24B

P2860

Genetics of antipsychotic-induced side effects and agranulocytosis.

http://www.wikidata.org/entity/Q37845227

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Genetics of antipsychotic-induced side effects and agranulocytosis.

@en

Genetics of antipsychotic-induced side effects and agranulocytosis.

@nl

type

label

Genetics of antipsychotic-induced side effects and agranulocytosis.

@en

Genetics of antipsychotic-induced side effects and agranulocytosis.

@nl

prefLabel

Genetics of antipsychotic-induced side effects and agranulocytosis.

@en

Genetics of antipsychotic-induced side effects and agranulocytosis.

@nl

P1433

Q37845227-66335EFF-99CA-4C06-8ABA-ACB85BF00BE7

P1476

Q37845227-C9A1FE27-992F-4E9F-9999-800566911598

P2093

Q37845227-EE6D9F0E-E65E-48BD-8C42-670BDC8897F8

Q37845227-F4EF7F5E-50D6-476D-AB12-AD3AF878465B

P2860

Q37845227-000C1ED5-5694-44D8-BB2A-FF64CB03B85A

Q37845227-01AFF7C9-7DE5-4211-91DF-FBBF796BC574

Q37845227-034C7180-C158-4223-9C71-0A9E6448B8D6

Q37845227-052E29D0-8C40-4CED-AC1D-32094F09F4A8

Q37845227-07AE3E81-D62D-4559-854D-A2A713A330B9

Q37845227-091E6A2D-DA2C-4B37-AF4D-B1C387729517

Q37845227-09B0C342-3487-48CC-BA0C-2210868ADD22

Q37845227-0E745236-0990-4839-9CAF-45996D99056E

Q37845227-14C3EC98-86E5-4460-87B1-2F4A85FADE12

Q37845227-158E653B-73A8-47F1-AE6C-886533997542

P2888

Q37845227-1CC63BA2-02BA-481D-A746-463DA71D2346

P304

Q37845227-0B806F69-BA40-429C-B20C-8388451295BD

P31

Q37845227-3D0B7C38-9A8F-47A9-BBBC-51DE58B4E302

P356

Q37845227-E77A5C27-FFDF-4307-A247-38B40C5CC054

P407

Q37845227-56D18327-B994-4B7D-BB8D-27D235C291E6

P433

Q37845227-9794DE95-98F1-4DF1-B998-8B19C18E623D

P478

Q37845227-49336936-040E-4825-A5B1-44BCF91B63BD

P50

Q37845227-A6973B3D-991D-46C3-8BCC-06C6B1B653C1

P577

Q37845227-9C3A7BFB-B3A6-49A3-A79F-6D855AD4F3AE

P698

Q37845227-717A91F7-F5E4-482E-BFFE-CBCACF181EBB

P356

S11920-011-0185-3

P1433

Current Psychiatry Reports

P1476

Genetics of antipsychotic-induced side effects and agranulocytosis.

@en

P2093

James L Kennedy

http://www.w3.org/2001/XMLSchema#string

Nabilah I Chowdhury

http://www.w3.org/2001/XMLSchema#string

P2860

Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia

NQO2 gene is associated with clozapine-induced agranulocytosis

Medical genetics: a marker for Stevens-Johnson syndrome

Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1

The Fas death factor

Genetics of antipsychotic treatment emergent weight gain in schizophrenia.

Association between the 1291-C/G polymorphism in the adrenergic α-2a receptor and the metabolic syndrome.

Atypical antipsychotics: are some more atypical than others?

An association between clozapine-induced agranulocytosis in schizophrenics and HLA-DQB1*0201.

A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms.

P2888

s11920-011-0185-3

P304

156-165

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11920-011-0185-3

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21336863

http://www.w3.org/2001/XMLSchema#string